Le Lézard
Classified in: Health
Subjects: TRI, FVT

Decrease the Burden of Oncology Clinical Trials with Patient-Friendly Technologies, Upcoming Webinar Hosted by Xtalks


In this free webinar, a former oncology clinical trial participant and cancer survivor?who is also a pharmaceutical R&D leader?will share some of her experiences as a clinical trial participant, including the impact of technology. She and other panelists will examine patient technologies such as electronic clinical outcome assessment (eCOA), connected devices, and more, with a focus on how a positive patient experience can have spillover effects for the site, sponsor, and overall trial.

TORONTO, April 3, 2024 /PRNewswire-PRWeb/ -- The burdens on oncology clinical trial participants are many. Professionals involved with the execution of clinical research should keep this top of mind when planning how to conduct a study. Patients, often feeling unwell even before the clinical trial commences, are impacted by every aspect of the experience, including the technologies they are required to use. One thing study teams can do to help minimize the burden on cancer patients is to seek technologies based on patient-centered design.

One thing study teams can do to help minimize the burden on cancer patients is to seek technologies based on patient-centered design.

In this webinar, a former oncology clinical trial participant and cancer survivor?who is also a pharmaceutical R&D leader?will share some of her experiences as a clinical trial participant, including the impact of technology. She and other panelists will examine patient technologies such as electronic clinical outcome assessment (eCOA), connected devices, and more, with a focus on how a positive patient experience can have spillover effects for the site, sponsor, and overall trial.

Join Rosie Filling, Vice President, Senior Global Head, R&D Operations, Endo International; Donna M. Mongiello, RN, BSN, Senior Vice President, eCOA Strategy, YPrime; and Terry Rehm, Head of Thought Leadership and Public Relations, YPrime, for the live webinar on Tuesday, April 23, 2024, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Helping to Decrease the Burden of Oncology Clinical Trials with Patient-Friendly Technologies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com 

SOURCE Xtalks


These press releases may also interest you

at 05:03
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI In Life Science Analytics Market ? By Component (Software, Hardware, Services), By Deployment (On-premise, Cloud), By Application (Research and...

at 05:02
According to the latest BCC Research study, the demand for Global Markets and Technologies for Nanofibers is growing from $2.9 billion in 2023 to $9.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.0% from 2023 through...

at 05:00
AxisCare, a leading provider of home care software, today released the findings of its independent survey, The Future of Homecare, conducted by Leading Home Care...a Tweed Jeffries company and the Homecare CEO Forum. The survey...

at 04:59
AMSilk GmbH ("AMSilk"), a frontrunner in advanced biomaterials made from spider silk-based proteins, today announces that Gudrun Vogtentanz, Chief Scientific Officer, will participate in a panel discussion titled 'Advancing the Bioeconomy:...

at 04:54
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global  In Vitro Diagnostic (IVD) Reagents Market ? (By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others), By Technology (Immunoassay,...

at 04:50
Corin Group, a pioneer in orthopaedic innovation, today announced the successful completion of first cases using the Apollotm platform and ApolloKneetm software for robotic-assisted total knee arthroplasty.   First user,...



News published on and distributed by: